Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsNeera Dahl, MD, PhD
Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Professor Adjunct
Director, Nephrology Clinical Trials Program, Nephrology
Positions outside Yale
Medical Director, Outpatient Dialysis, Nephrology, DaVita New Haven
Biography
Dr. Dahl has expertise in diagnosis and management of inherited (or genetically based) kidney disease. Her main focus has been ADPKD and other cystic kidney diseases which mimic ADPKD. She is the medical director of the New Haven DaVita unit providing in center hemodialysis, home hemodialysis and peritoneal dialysis. She is the Director of the Nephrology Clinical Trials program overseeing studies in ADPKD, diabetes and hypertension. In collaboration with Dr. Dinesh Singh she runs the Yale Kidney Stone Clinic.
Last Updated on April 07, 2025.
Appointments
Nephrology
Professor AdjunctPrimary
Other Departments & Organizations
- All Institutions
- Internal Medicine
- Nephrology
- Prostate & Urologic Cancers Program
- Yale Cancer Center
- Yale Ventures
Education & Training
- Fellow
- Beth Israel Deaconess Medical Center (2002)
- Resident
- Beth Israel Deaconess Medical Center (1999)
- Intern
- BIDMC, Harvard Medical School (1997)
- PhD
- Tufts University (1996)
- MD
- Tufts University School of Medicine (1996)
- BA
- Johns Hopkins University (1987)
- Postdoctoral, PhD
- Tufts University School of Medicine and Sackler School of Biomedical Science
Research
Copy Link
Overview
In collaboration with Dr. Tinika Montgomery (nephrology), Drs. Dinesh Singh, Piruz Motamedinia, and Tim Tran (urology) we have created a Kidney Stone Registry to track important aspects of kidney stone management.
In the inherited kidney disease space I am most interested in those aspects of clinical research which improve care for ADPKD patients.
Medical Research Interests
Kidney Diseases; Nephrology
ORCID
0000-0001-5809-9961
Research at a Glance
Yale Co-Authors
Frequent collaborators of Neera Dahl's published research.
Publications Timeline
A big-picture view of Neera Dahl's research output by year.
Research Interests
Research topics Neera Dahl is interested in exploring.
Whitney Besse, MD
Stefan Somlo, MD
Cassius Iyad Ochoa Chaar, MD, MPH, MS, RPVI
Gilbert Moeckel, MD, PhD, FASN
Abinet Aklilu, MD, MPH
Margaret Bia, MD
111Publications
1,560Citations
Kidney Diseases
Nephrology
Publications
2026
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Dahl N, August P, Besse W, Chebib F, Chonchol M, Cowley B, Goral S, Guay-Woodford L, Gulati A, Hogan M, Lakhia R, Miskulin D, Nowak K, Rahbari-Oskoui F, Park M, Seliger S, Yu A, Watnick T. KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). American Journal Of Kidney Diseases 2026, 87: 447-507. PMID: 41864657, DOI: 10.1053/j.ajkd.2025.11.006.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsKidney Disease Outcomes Quality InitiativeAutosomal dominant polycystic kidney diseaseClinical practice guidelinesTreatment of autosomal dominant polycystic kidney diseaseDominant polycystic kidney diseasePolycystic kidney diseasePractice guidelinesKDIGO guidelinesKidney diseaseContext of clinical practiceWorking GroupChronic kidney disease managementHigh-quality evidenceProgression of diseaseKidney disease managementEvidence baseExtrarenal manifestationsKidney manifestationsKDIGODisease managementQuality InitiativeGuideline statementsClinical practiceGuidelinesDiseaseMonogenic Etiologies of Kidney Cysts in the Pediatric Population: An Observational Cohort Study.
Bozkurt E, Najeeb M, Yang H, Kemppainen J, Smith B, Gregory A, Baker T, Thompson W, Khalifa M, Cruz C, Kouri A, Tran C, Sas D, Cramer C, Dahl N, Kline T, Torres V, Chebib F, Harris P, Hanna C. Monogenic Etiologies of Kidney Cysts in the Pediatric Population: An Observational Cohort Study. Clinical Journal Of The American Society Of Nephrology 2026 PMID: 41790507, DOI: 10.2215/cjn.0000001027.Peer-Reviewed Original ResearchAltmetricConceptsComprehensive genetic testingPositive family historyFamily historyGenetic testingObservational cohort studyCohort studyDiagnostic yieldKidney cystsMonogenic etiologyGenetic diagnosisDistribution of pathogenic variantsAbsence of family historyEligible participantsPrimary outcomePrenatal ultrasoundFamily screeningTertiary centerClinical presentationCongenital anomaliesADPKD genesPediatric cohortPKD1 variantsEchogenic kidneysSequencing panelUnilateral cystsCharacterization of Kidney and Liver Cystic Phenotype Associated with GANAB Using Advanced Imaging Biomarkers.
Munairdjy Debeh F, Bou Antoun M, Ghanem A, Rangarajan V, Borghol A, Paul S, Hanna D, AlKhatib B, Nader N, Shami B, Gregory A, Yang H, Schauer R, Zoghby Z, Hogan M, Dahl N, Hanna C, Kline T, Harris P, Chebib F. Characterization of Kidney and Liver Cystic Phenotype Associated with GANAB Using Advanced Imaging Biomarkers. Nephron 2026, 1-22. PMID: 41774594, DOI: 10.1159/000551274.Peer-Reviewed Original ResearchConceptsHeight-adjusted total kidney volumeGenotype-phenotype relationshipsMonoallelic pathogenic variantsPathogenic variantsEGFR declineGANABKidney involvementLiver volumePhenotypic associationsLiver diseasePhenotypic spectrumQuantitative imaging phenotypesAdvanced imaging biomarkersCystic kidneysAnnual eGFR declineTotal kidney volumePolycystic liver diseasePhenotypeCyst volumeKidney volumeHepatic involvementRetrospective studyAneurysmal diseaseAbdominal imagingKidney functionEvolution of Clinical Trial Design in ADPKD
Roth J, Dahl N, Garimella P. Evolution of Clinical Trial Design in ADPKD. Kidney International Reports 2026, 11: 103786. PMID: 41736773, PMCID: PMC12926507, DOI: 10.1016/j.ekir.2026.103786.Peer-Reviewed Original ResearchConceptsAutosomal dominant polycystic kidney diseaseTotal kidney volumeEstimated glomerular filtration ratePolycystic kidney diseaseClinical trial designKidney volumeKidney diseaseEnd pointsTrial designDevelopment of therapeutic optionsRadiologic imaging studiesDominant polycystic kidney diseaseGlomerular filtration rateSurrogate end pointsKidney function outcomesFunctional end pointsRenal functionTherapeutic optionsFiltration ratePrognostic biomarkerFunctional outcomesImaging studiesKidney failureIntervention trialsKidney cysts
2025
ARPKD With Shrinking Kidneys and Progressive Loss of Kidney Function
Arriola-Montenegro J, Mohan A, Gregory A, Kline T, Harris P, Dahl N. ARPKD With Shrinking Kidneys and Progressive Loss of Kidney Function. Kidney International Reports 2025, 11: 103755. PMID: 41624451, PMCID: PMC12860245, DOI: 10.1016/j.ekir.2025.103755.Peer-Reviewed Original ResearchAltmetricResolution of acute kidney injury following intensive dialysis for oxalate nephropathy.
Roth J, Buglioni A, Dahl N. Resolution of acute kidney injury following intensive dialysis for oxalate nephropathy. Clinical Nephrology 2025, 104: 440-445. PMID: 40454527, DOI: 10.5414/cn111664.Peer-Reviewed Original ResearchConceptsAcute kidney injuryOxalate nephropathyKidney injuryStage III acute kidney injuryIII acute kidney injuryResolution of acute kidney injuryUrinary excretion of oxalateIncreased urinary excretion of oxalateAbsorption of dietary oxalateDeposition of calcium oxalate crystalsIncreased absorption of dietary oxalateSerum oxalate levelsExcretion of oxalateIncreased urinary excretionChronic kidney diseaseRenal outcomesRenal recoveryEnteric hyperoxaluriaBariatric proceduresFat malabsorptionIntensive dialysisSecondary hyperoxaluriaRenal parenchymaBiliopancreatic diversionBariatric patientsKidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review
Borghol A, Azooz M, Bou Antoun M, Souvalian L, Shami B, Mina J, Munairdjy Debeh F, Ghanem A, Sandouk H, Rangarajan V, Hanna D, Naranjo C, Drexler Y, Norouzi S, Noruzi A, Salih M, Klett D, Porter I, Dahl N, Chebib F. Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. Renal Failure 2025, 47: 2570071. PMID: 41208250, PMCID: PMC12604128, DOI: 10.1080/0886022x.2025.2570071.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsAutosomal dominant polycystic kidney diseaseVasopressin V2 receptor antagonistNon-Contrast Computed TomographyCorrection of metabolic derangementsImpaired urinary drainageV2 receptor antagonistLow urine pHTreatment of stone diseaseStone-free rateDominant polycystic kidney diseaseDiagnostic gold standardCumulative radiation exposureLow-dose CTPolycystic kidney diseaseCalcium oxalate stonesLonger operative timeReceptor antagonistUrological interventionUrinary drainageUrine volumeAggressive hydrationDiagnostic challengeClinical manifestationsMetabolic abnormalitiesStone riskGenetic Testing in the Management of Adult CKD.
Chebib F, Wang X, Udani S, Westemeyer M, Clark D, Zhang Z, Bloom M, Milo Rasouly H, Kolupaeva V, Mizani M, Dossabhoy N, Faravardeh A, Demko Z, Kotte S, Punj S, Chapman S, Rabinowitz M, Schneider R, Tabriziani H, Bhorade S, Gharavi A, Dahl N. Genetic Testing in the Management of Adult CKD. Journal Of The American Society Of Nephrology 2025 PMID: 41563380, DOI: 10.1681/asn.0000000913.Peer-Reviewed Original ResearchCitationsAltmetricConceptsGenetic testingPositive test findingsImpact of genetic testingAdoption of genetic testingHealth care systemManagement of CKDClinical utilityPublic health burdenTest findingsClinical managementPositive genetic findingsCare systemDiabetes-related nephropathyPhysician estimatesPrognosis of patientsHealth burdenCKD diagnosisSuboptimal managementSingle-armStudy patientsMulticenter studyCKD patientsClinical historyClinical cohortQuestionnaireRefining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease
Dahl N, Torres V. Refining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease. Kidney360 2025, 7: 190-191. PMID: 41148212, PMCID: PMC12889975, DOI: 10.34067/kid.0000001039.Peer-Reviewed Original ResearchAltmetricAutosomal Recessive PKD: Not Just for Kids, Long-Term Outcomes in Early vs. Late-Onset Disease
Borghol A, Potretzke T, Gregory A, Yang H, Smith B, Elbarougy D, Thompson W, Dahl N, Torres V, Gitomer B, Ong A, Chebib F, Harris P, Hanna C. Autosomal Recessive PKD: Not Just for Kids, Long-Term Outcomes in Early vs. Late-Onset Disease. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.2025bf6aaxjq. DOI: 10.1681/asn.2025bf6aaxjq.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Activities
activity Scientific Advisory Board
10/01/2018 - PresentAdvisory BoardsAdvisorDetailsPKD Foundationinvolved in grant review and patient outreach projects with the PKD Foundationactivity Medical Review Board
10/01/2015 - PresentAdvisory BoardsBoard MemberDetailsESRD Network of New EnglandHelped determine focus of the ESRD Network projectsactivity National Kidney Foundation, CT Chapter
10/01/2008 - PresentAdvisory BoardsBoard MemberDetailsNational Kidney Foundationactivity American Journal of Kidney Disease
2007 - PresentJournal ServiceRevieweractivity Clinical Journal of the American Society of Nephrology
2007 - PresentJournal ServiceReviewer
Honors
honor ISN Travel Grant
01/01/2013National AwardWorld Congress of NephrologyDetailsUnited Stateshonor Sugarman Postdoctoral Training Grant
01/01/2002, 01/01/2001National AwardNational Kidney FoundationDetailsUnited Stateshonor Training Grant (Renal Fellow)
01/01/2001, 01/01/2000Other AwardHarvard Medical SchoolDetailsUnited Stateshonor Medical Scientist Training Program
01/01/1996, 01/01/1987Regional AwardTufts UniversityDetailsUnited Stateshonor Alpha Omega Alpha
01/01/1996Other AwardTufts University School of MedicineDetailsUnited States
News
Copy Link
News
- February 15, 2024
Hybrid Approach to Arteriovenous Fistula Aneurysm Repair
- July 13, 2023
Support System, Consistency Important For Dialysis Patients During Pandemic (Discoveries & Impact July 2023)
- December 19, 2022
Yale Named Center of Excellence by Polycystic Kidney Disease (PKD) Foundation
- November 12, 2022Source: Web MD
Talking to Your Kids About ADPKD
Get In Touch
Copy Link
Contacts
Email